health
-
Experimental vaccine protects mice against fentanyl and related opioids in new study
HOUSTON, July 13 — On the ground in the fight against the opioid crisis, researchers at the University of Houston and the…
-
Choline Deficiency Linked to Anxiety and Brain Chemistry
ISLAMABAD, July 10 — A new look at brain imaging data suggests that people with anxiety disorders may have measurably lower levels…
-
Innate Immune System Provides Immediate Defense Against Pathogens
ROME, July 10 — For years, the story of immunity has been told through the lens of vaccines and antibodies — the…
-
Human Immune System: How It Defends the Body Against Pathogens,
WASHINGTON, July 10 — The human immune system operates as a coordinated network of cells, tissues, and organs that defends the body…
-
Aubrey de Grey: Radical Life Extension via Damage Repair
LONDON, July 10 — Aubrey de Grey, the British biomedical gerontologist whose radical vision of defeating aging has made him a polarizing…
-
Critics Question Harvard’s Sinclair Over Unproven Anti-Aging Claims and Supplement Ties
BOSTON, July 10 — The longevity research community is confronting a widening credibility gap, and Dr. David Sinclair, the Harvard Medical School…
-
Katalin Karikó’s mRNA research wins 2023 Nobel Prize
LONDON, July 10 — The detail that matters in the story of Katalin Karikó is not the Nobel Prize, nor the 95%…
-
Decades of mRNA Research Led to Fastest Vaccines by 2020
ROME, July 10 — The story of messenger RNA vaccines begins not in a pandemic, but in a laboratory mouse. In 1990,…
-
Immunotherapy Side Effects Affect More Than 60% of Patients, MD Anderson Says
WASHINGTON, July 10 — The strategic calculus of cancer treatment is shifting, and with it comes a new set of battlefield risks…
-
FDA Immunotherapy Approvals Reach 156 Since 2011, Cancer Research Institute Reports
WASHINGTON, July 10 — The first checkpoint inhibitor landed in March 2011, a drug called ipilimumab, approved for melanoma. Since then, the…
-
Vaccination’s Journey: From Ancient Variolation to Modern Immunization
ROME, July 10 — The record of vaccination begins with a single act in 1796, when English physician Edward Jenner used material…
-
Nobel Laureate Dr. James Allison’s CTLA-4 discovery launched immunotherapy
HOUSTON, July 10 — The man who taught the immune system to fight cancer has spent the better part of three decades…
-
UCSF team reprograms T cells inside the body to clear cancer in mice
ISLAMABAD, July 10 — For patients and families facing blood cancers, the word “remission” carries a weight that is both fragile and…
-
New Study Targets GATA6 to Prevent Colorectal Cancer Spread
NEW YORK, July 8 — A study published June 22 in the journal *Cell Stem Cell* has identified a molecular mechanism that…
-
Researchers uncover how colorectal cancer cells spread to other organs
NEW YORK, July 8 — A newly published study from researchers at Weill Cornell Medicine and the Massachusetts Institute of Technology has…
-
Queen Mary team’s brush swab detects oral cancer in under an hour
LONDON, July 8 — Against the backdrop of a global struggle to catch cancer early, researchers at Queen Mary University of London…
-
Sea Squirt Compound Shows Promise Against Melanoma Cells
NEW YORK, July 8 — 1%. That figure that matters: melanoma accounts for about 1% of all skin cancers, yet it causes…
-
Sea Squirt from Antarctic Depths Holds Promise for Melanoma Treatment
ANTARCTICA, July 8 — A marine organism discovered during a scientific expedition to Antarctica is now being studied as a potential new…
-
Senolytics: Clearing Senescent Cells to Combat Age-Related Disease
ROCHESTER, Minnesota, July 8 — For a field that began with a single question about aging cells, senolytic research has come a…
-
Metformin and Rapamycin: Two Anti-Aging Drug Candidates With Very Different Evidence
NEW YORK, July 8 — The calculus around aging research is shifting. Two drugs, one a decades-old diabetes staple and the other…
-
Alzheimer’s in America: 6.9 million patients and $360 billion in care costs in 2024
WASHINGTON, July 8 — The numbers arrive with the cold weight of an epidemic that refuses to recede. By 2024, an estimated…
-
FDA Approves Breyanzi CAR-T Therapy for Relapsed Chronic Lymphocytic Leukemia
MANILA, July 7 — For families across the region watching loved ones battle blood cancers that keep returning, a new treatment option…
-
Rye pollen compounds’ structures unlocked after decades for cancer research
CHICAGO, July 7 — Nearly 30 years ago, researchers discovered two unusual molecules in rye pollen that appeared to slow tumor growth…
-
Northwestern Chemists Confirm Structures of Two Rye Pollen Molecules Tied to Tumor Clearance in Animals
MANILA, July 7 — A team of scientists has identified two new molecules from rye pollen that could one day change how…
Most read
-
Martin Lewis Warns Savers With £10,000 or More They Could Owe Tax on Interest
-
Asian & Oceanian Epilepsy Congress 2026 in Kuala Lumpur
-
Baby & Beyond Maternity Expo in Kuala Lumpur 2026
-
Axos Offers 5.00% Savings Rate for Six Months After Fed Hike, With Strings Attached
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
-
FDA orders class-wide GLP-1 label update for rare eye disease risk
-
Why Oncology Trials Chase Surrogate Endpoints the FDA Ignores
-
Understanding Metastatic Prostate Cancer Prognosis and Modern Treatment Pathways
-
Nangibotide Targets Acute-on-Chronic Liver Failure With Phase 2 Data Due 2027
-
SABR Versus Surgery: New Study Reveals Mortality Gap for Early-Stage Lung Cancer
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992